As of 2025-07-03, the EV/EBITDA ratio of Marinus Pharmaceuticals Inc (MRNS) is -0.36. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRNS's latest enterprise value is 43.38 mil USD. MRNS's TTM EBITDA according to its financial statements is -121.83 mil USD. Dividing these 2 quantities gives us the above MRNS EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
Range | Selected | |
Trailing P/E multiples | 7.5x - 8.6x | 8.1x |
Forward P/E multiples | 6.2x - 10.4x | 8.4x |
Fair Price | (16.69) - (19.21) | (18.49) |
Upside | -3135.2% - -3592.5% | -3462.2% |
Date | EV/EBITDA |